213 related articles for article (PubMed ID: 35158083)
1. Trends in Incidence and Survival of Patients With Thymic Epithelial Tumor in a High-Incidence Asian Country: Analysis of the Korean Central Cancer Registry 1999 to 2017.
Shin DW; Cho JH; Ha J; Jung KW
J Thorac Oncol; 2022 Jun; 17(6):827-837. PubMed ID: 35158083
[TBL] [Abstract][Full Text] [Related]
2. The maximal contrast-enhanced range of CT for differentiating the WHO pathological subtypes and risk subgroups of thymic epithelial tumors.
Yu C; Li T; Yang X; Xin L; Zhao Z; Yang Z; Zhang R
Br J Radiol; 2023 Oct; 96(1150):20221076. PubMed ID: 37486626
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians.
Sakakura N; Tateyama H; Nakamura S; Taniguchi T; Usami N; Ishikawa Y; Kawaguchi K; Yokoi K
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):89-95. PubMed ID: 23229995
[TBL] [Abstract][Full Text] [Related]
4. Trends in the incidence of thymoma, thymic carcinoma, and thymic neuroendocrine tumor in the United States.
Hsu CH; Chan JK; Yin CH; Lee CC; Chern CU; Liao CI
PLoS One; 2019; 14(12):e0227197. PubMed ID: 31891634
[TBL] [Abstract][Full Text] [Related]
5. High levels of expression of Trop-2 in thymic epithelial tumors.
Yeung V; Zaemes J; Yeh J; Giancarlo C; Ahn J; Reuss JE; Kallakury BV; Liu SV; Duttargi A; Khan G; Kim C
Lung Cancer; 2023 Oct; 184():107324. PubMed ID: 37573703
[TBL] [Abstract][Full Text] [Related]
6. Predicting pathological subtypes and stages of thymic epithelial tumors using DWI: value of combining ADC and texture parameters.
Li B; Xin YK; Xiao G; Li GF; Duan SJ; Han Y; Feng XL; Yan WQ; Rong WC; Wang SM; Hu YC; Cui GB
Eur Radiol; 2019 Oct; 29(10):5330-5340. PubMed ID: 30877464
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
[TBL] [Abstract][Full Text] [Related]
8. The tumor doubling time is a useful parameter for predicting the histological type of thymic epithelial tumors.
Fukumoto K; Fukui T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Mori S; Goto M; Hashimoto K; Tateyama H; Yokoi K
Surg Today; 2019 Aug; 49(8):656-660. PubMed ID: 31134370
[TBL] [Abstract][Full Text] [Related]
9. Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation.
Bellissimo T; Ganci F; Gallo E; Sacconi A; Tito C; De Angelis L; Pulito C; Masciarelli S; Diso D; Anile M; Petrozza V; Giangaspero F; Pescarmona E; Facciolo F; Venuta F; Marino M; Blandino G; Fazi F
Mol Cancer; 2017 May; 16(1):88. PubMed ID: 28486946
[TBL] [Abstract][Full Text] [Related]
10. Doubling time of thymic epithelial tumours on CT: correlation with histological subtype.
Choe J; Lee SM; Lim S; Choi SH; Kim N; Do KH; Seo JB
Eur Radiol; 2017 Oct; 27(10):4030-4036. PubMed ID: 28332015
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the effectiveness of chemotherapy for thymic epithelial tumors using the CD-DST method.
Yu L; Zhang BX; Du X; Yu Z; Yang XG; Jiang YX
Thorac Cancer; 2020 May; 11(5):1160-1169. PubMed ID: 32196982
[TBL] [Abstract][Full Text] [Related]
12. Expression Patterns, Prognostic Value, and Intratumoral Heterogeneity of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma.
Owen D; Chu B; Lehman AM; Annamalai L; Yearley JH; Shilo K; Otterson GA
J Thorac Oncol; 2018 Aug; 13(8):1204-1212. PubMed ID: 29702286
[TBL] [Abstract][Full Text] [Related]
13. Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.
Thomas A; Chen Y; Berman A; Schrump DS; Giaccone G; Pastan I; Venzon DJ; Liewehr DJ; Steinberg SM; Miettinen M; Hassan R; Rajan A
Lung Cancer; 2016 Nov; 101():104-110. PubMed ID: 27794397
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses.
Ishihara S; Okada S; Ogi H; Kodama Y; Shimomura M; Tsunezuka H; Itoh K; Marx A; Inoue M
Lung Cancer; 2020 Jul; 145():40-47. PubMed ID: 32402921
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of
Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
[TBL] [Abstract][Full Text] [Related]
16. Prognostic CT features in patients with untreated thymic epithelial tumors.
Dai H; Lan B; Li S; Huang Y; Jiang G; Tian J
Sci Rep; 2023 Feb; 13(1):2910. PubMed ID: 36801902
[TBL] [Abstract][Full Text] [Related]
17. Dual-energy CT perfusion imaging for differentiating WHO subtypes of thymic epithelial tumors.
Yu C; Li T; Zhang R; Yang X; Yang Z; Xin L; Zhao Z
Sci Rep; 2020 Mar; 10(1):5511. PubMed ID: 32218504
[TBL] [Abstract][Full Text] [Related]
18. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
Yamada Y
Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
[TBL] [Abstract][Full Text] [Related]
19. Histotyping of Indian thymomas: A clinicopathologic study from north India.
Guleria P; Parshad R; Malik PS; Ray R; Pandey RM; Jain D
Indian J Med Res; 2019 Aug; 150(2):153-160. PubMed ID: 31670270
[TBL] [Abstract][Full Text] [Related]
20. Extracellular volume fraction measurement correlates with lymphocyte abundance in thymic epithelial tumors.
Chang CC; Lin CY; Chu CY; Hsiung YC; Chuang MT; Tseng YL; Yen YT
Cancer Imaging; 2020 Oct; 20(1):71. PubMed ID: 33028413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
